Mechanism of Action of Imipramine

Introduction

Imipramine is a tricyclic antidepressant (TCA) widely used in the management of major depressive disorder, anxiety disorders, and certain pediatric conditions such as nocturnal enuresis. It is one of the prototype TCAs and exhibits both antidepressant and sedative properties. Its pharmacological effects are primarily mediated through modulation of monoamine neurotransmitters in the central nervous system.

Mechanism of Action (Step-wise)

1. Inhibition of Monoamine Reuptake
   Imipramine inhibits the reuptake of norepinephrine (NE) and serotonin (5-HT) by blocking their respective transporters (NET and SERT) at presynaptic nerve terminals.
2. Increased Synaptic Neurotransmitter Levels
   This inhibition leads to increased concentrations of NE and 5-HT in the synaptic cleft.
3. Enhanced Neurotransmission
   Elevated monoamine levels enhance stimulation of postsynaptic receptors, contributing to antidepressant effects.
4. Downregulation of Receptors (Chronic Effect)
   Long-term use leads to downregulation and desensitization of β-adrenergic and serotonin receptors, which is associated with therapeutic efficacy.
5. Anticholinergic Activity
   Imipramine blocks muscarinic receptors, contributing to side effects such as dry mouth and urinary retention.
6. Antihistaminic Effect
   It blocks H1 receptors, leading to sedation.
7. Alpha-1 Adrenergic Blockade
   Causes vasodilation and may lead to orthostatic hypotension.

Pharmacokinetics

• Absorption: Well absorbed after oral administration
• First-pass metabolism: Significant hepatic metabolism
• Active metabolite: Desipramine (more selective for norepinephrine reuptake inhibition)
• Protein Binding: High
• Half-life: 8–20 hours (longer for metabolite)
• Excretion: Renal (as metabolites)

Clinical Uses

• Major depressive disorder
• Anxiety disorders
• Panic disorder
• Nocturnal enuresis (bedwetting) in children
• Neuropathic pain (off-label)

Adverse Effects

• Anticholinergic effects: dry mouth, blurred vision, constipation, urinary retention
• Sedation (due to H1 blockade)
• Orthostatic hypotension (α1 blockade)
• Cardiotoxicity (arrhythmias, conduction defects)
• Weight gain
• CNS effects: confusion, delirium (especially in elderly)

Comparative Analysis

Imipramine is less sedating and has slightly fewer anticholinergic effects compared to amitriptyline but still carries significant TCA-related risks. Compared to SSRIs like fluoxetine, it has broader receptor activity but a less favorable safety profile.

MCQs

1. Imipramine primarily inhibits:
   a) Dopamine reuptake
   b) GABA receptors
   c) Norepinephrine and serotonin reuptake
   d) NMDA receptors
   Answer: c) Norepinephrine and serotonin reuptake
2. Active metabolite of imipramine:
   a) Nortriptyline
   b) Desipramine
   c) Fluoxetine
   d) Sertraline
   Answer: b) Desipramine
3. Which receptor blockade causes dry mouth?
   a) Dopamine
   b) Muscarinic
   c) NMDA
   d) GABA
   Answer: b) Muscarinic
4. Sedation with imipramine is due to:
   a) H2 blockade
   b) H1 blockade
   c) Beta blockade
   d) Dopamine blockade
   Answer: b) H1 blockade
5. Orthostatic hypotension is due to:
   a) Alpha-1 blockade
   b) Beta-2 blockade
   c) Serotonin blockade
   d) Calcium channel blockade
   Answer: a) Alpha-1 blockade
6. Imipramine is used in:
   a) Hypertension
   b) Depression
   c) Diabetes
   d) Asthma
   Answer: b) Depression
7. Cardiotoxicity is a concern because:
   a) Sodium channel blockade
   b) Calcium channel activation
   c) Potassium depletion
   d) Insulin release
   Answer: a) Sodium channel blockade
8. Which class does imipramine belong to?
   a) SSRI
   b) MAOI
   c) TCA
   d) Benzodiazepine
   Answer: c) TCA
9. Imipramine increases which neurotransmitters?
   a) Dopamine only
   b) GABA
   c) NE and 5-HT
   d) Acetylcholine
   Answer: c) NE and 5-HT
10. Major side effect in elderly:
    a) Hypertension
    b) Delirium
    c) Hyperglycemia
    d) Hair loss
    Answer: b) Delirium

FAQs

1. What is the primary mechanism of action of imipramine?
   It inhibits reuptake of norepinephrine and serotonin, increasing their synaptic levels.
2. Why does imipramine cause sedation?
   Due to histamine H1 receptor blockade.
3. What is the role of desipramine?
   It is an active metabolite with stronger norepinephrine reuptake inhibition.
4. Why is imipramine used in enuresis?
   It reduces bladder contractility and increases sphincter tone.
5. What makes TCAs risky in overdose?
   They cause cardiac arrhythmias due to sodium channel blockade.
6. Is imipramine safer than SSRIs?
   No, SSRIs generally have a better safety profile.

References

• Goodman & Gilman’s The Pharmacological Basis of Therapeutics – Antidepressants
• Katzung: Basic and Clinical Pharmacology – Antidepressant Drugs
• Tripathi: Essentials of Medical Pharmacology
• Harrison’s Principles of Internal Medicine

Download